Antipodes Partners’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145M Buy
1,285,233
+13,647
+1% +$1.51M 2.66% 10
2026
Q1
$140M Buy
1,271,586
+28,095
+2% +$3M 2.69% 10
2025
Q4
$124M Sell
1,243,491
-127,267
-9% -$13M 2.61% 13
2025
Q3
$143M Buy
1,370,758
+1,369,450
+104,698% +$137M 3.21% 11
2025
Q2
$126K Hold
1,308
﹤0.01% 69
2025
Q1
$131K Sell
1,308
-891
-41% -$85.8K ﹤0.01% 66
2024
Q4
$196K Sell
2,199
-1,262,004
-100% -$113M 0.01% 58
2024
Q3
$111M Buy
1,264,203
+160,638
+15% +$12.9M 3.83% 6
2024
Q2
$78.5M Buy
1,103,565
+726,404
+193% +$52.8M 2.85% 15
2024
Q1
$27.9M Buy
+377,161
New +$26.8M 0.88% 30

Other funds holding AEE

Antipodes Partners's AEE Position: Q2 2026 in Review

Antipodes Partners increased its Ameren (AEE) stake by 1.1% in Q2 2026, buying an estimated $1.51M and bringing the position to 1,285,233 shares worth $145M. The position accounts for 2.66% of the portfolio, ranked #10.

Antipodes Partners first reported a position in AEE in Q1 2024 and has held it in 10 quarters since. 951 funds tracked by Wall St. Rank hold AEE as of Q2 2026.

  • Antipodes Partners held 1,285,233 shares of Ameren worth $145M as of Q2 2026.
  • Antipodes Partners bought 13,647 Ameren shares in Q2 2026, an estimated $1.51M.
  • Ameren made up 2.66% of Antipodes Partners's portfolio in Q2 2026, its #10 holding.
  • Antipodes Partners first reported a position in Ameren in Q1 2024 and has held it in 10 quarters since.
  • 951 funds tracked by Wall St. Rank held Ameren as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.